Skip to main content
Log in

Beneficial effects of fructose-1,6-diphosphate infusion on liver regeneration after ischemie liver injury

  • Liver, Pancreas, and Biliary Tract
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

The effect of fructose-1,6-diphosphate (FDP) on cellular viability after partial hepatectomy in partial ischemie liver was investigated in rats. The administration of FDP did not increase blood flow in the hepatic tissue; however, it significantly suppressed the elevation of serum liver functions for 24 hours after partial hepatectomy. Levels of DNA synthesis, protein synthesis, and labeling index were significantly higher in the groups administered divided doses of FDP before and after partial hepatic ischemia than in the control group (P< 0.01). Thus, these findings indicate that FDP has cytoprotective and hepatotrophic effects on liver with ischemie injury and that divided dose administration of FDP is more effective than bolus doses in decreasing damage following ischemie and reperfusion injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Markov AK: Hemodynamics and metabolic effects of fructose-1,6-diphosphate in ischemia and shock; experimental and clinical observations. Ann Emcrg Mcd 1986; 15:1470–1477.

    Article  CAS  Google Scholar 

  2. Markov AK, Oglcthorpe NC, Blake TM, et al: Hcmodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. Am Heart J 1980:100:639–646.

    Article  PubMed  CAS  Google Scholar 

  3. Didlakc R, Kirchner KA, Lewin J, et al: Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rat. Cir Shock 1985:16:206–212.

    Google Scholar 

  4. Higgins GM and Anderson RM: Experimental pathology of the liver, I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931:12:186–202.

    Google Scholar 

  5. Morstyn G, Hsu SM, Kinsella T, et al: Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest 1983:72:1844–1850.

    Article  PubMed  CAS  Google Scholar 

  6. IaBrecque DR, Pesch IA: Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 1975:248:273–284.

    Google Scholar 

  7. Schneider WC: Phosphorus compounds in animal tissue. I. Extraction and estimation of desoxypentose nucleic acid and pentose nucleic acid. J Biol Chem 1945:161:293–303.

    CAS  Google Scholar 

  8. Burton K: A study of the conditions and mechanism of the diphenylamine reaction for the colorimctric estimation of deoxyribonucleic acid. Biochem J 1956:62:315–323.

    PubMed  CAS  Google Scholar 

  9. Lowry OH, Rosenbrough NJ, Farr AL, et al: Protein measurement with folin phenol reagent. J Biol Chem 1951:193:265–271.

    PubMed  CAS  Google Scholar 

  10. Kirtley ME, McKay M: Fructose-1,6-bisphosphate, a regulator of metabolism. Mol Cell Biochem 1977:18:141–149.

    Article  PubMed  CAS  Google Scholar 

  11. Iapichino G, Radrizzani D, Leoni ML, et al: Parentcral nutrition of critically ill patients; increasing protein sparing effect with fructose-l,6-diphosphate. IRCS Med Sci 1983:11:821–822.

    CAS  Google Scholar 

  12. Giordano C, Santo NGD: Metabolic aspects of fructose diphosphatc in total parenteral nutrition. IRCS Med Sc 1983:11:173–174.

    CAS  Google Scholar 

  13. Rao SB, Mehendale HM: Protective role of fructose-1,6-bisphosphatc during CCl4 hepatotoxicity in rats. Biochem J 1989:262:721–725.

    PubMed  CAS  Google Scholar 

  14. Weber A, Schapira F: Les isozymes de l’aldolase du foie en regeneration. Biologie 1972:166:312–317.

    CAS  Google Scholar 

  15. Galzigna L, Manai G, Giron GP, et al: Enzymatic assay of fructose-1,6-diphosphate for the measurement of its utilization by tissues. Int J Vitam Nutr Res 1977:47:88–91.

    PubMed  CAS  Google Scholar 

  16. Rigobello MP, Bianchi M, Deana R, et al: Interaction of fructose-1,6-diphosphate with some cell membranes. Aggressologie 1982;23:63–66.

    CAS  Google Scholar 

  17. Grisham JW: A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in thymidinc-3H. Cancer Res 1962;22:842–849.

    PubMed  CAS  Google Scholar 

  18. Sharma GP, Varley KG, Kim SW, et al: Alteration in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion. Am J Cardiol 1975;36: 234–243.

    Article  CAS  Google Scholar 

  19. Hasselgren PO: Prevention and treatment of the liver. Surg Gynecol Obstet 1987;164:187–196.

    PubMed  CAS  Google Scholar 

  20. Cattani L, Costrini R, Cerilli C, et al: Fructosc-l,6-diphosphate dependence on the toxicity and uptake of potassium ions. Aggressologie 1980;21:263–264.

    CAS  Google Scholar 

  21. Hasselgren PO, Biber B, Fornander J: Improved blood flow and protein synthesis in the postischemic liver following infusion of dopamine. J Surg Res 1983;34:44–52.

    Article  PubMed  CAS  Google Scholar 

  22. Chlouverakis C: The lipolytic action of fructose-1,6-diphosphate. Metabolism 1968;17:708–716.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakai, T., Tanimura, H., Tabuse, K. et al. Beneficial effects of fructose-1,6-diphosphate infusion on liver regeneration after ischemie liver injury. Gastroenterol Jpn 26, 611–618 (1991). https://doi.org/10.1007/BF02781677

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02781677

Key words

Navigation